BIRNA

Research · Gut–Brain Axis

Routes of microbiota–gut–brain communication

Neural · Immune · Endocrine · Metabolic

Birna Ásbjörnsdóttir, PhDResearch synthesis / scientific explainer

Evidence classification: Mechanistic · Editorial synthesis

The microbiota–gut–brain axis is often described as a communication system linking the intestinal microbiota with the central nervous system.

That description is useful, but incomplete.

There is no single microbiota–gut–brain pathway. Communication emerges through several interacting biological systems: neural signalling, immune activity, endocrine and stress physiology, microbial and host metabolism, intestinal-barrier function and the circulation.¹–⁴ Signals can originate in the intestinal environment, be transformed by epithelial or immune cells, travel through peripheral nerves or the bloodstream and influence neural function. Communication also runs in the opposite direction: the brain can alter intestinal motility, secretion, immune activity, barrier physiology and the microbial habitat itself.¹–⁵

The axis is therefore not a direct cable connecting microorganisms to the brain.

It is a distributed, bidirectional system.

This distinction matters because phrases such as “the gut sends signals to the brain” can compress several biological steps into one statement. A microbial change may alter metabolite production; a metabolite may act locally on epithelial or immune cells; those cells may modify neural, endocrine or circulating signals; and the resulting host response may influence the brain. At each stage, the signal can be amplified, modified or stopped.

Understanding microbiota–gut–brain communication therefore requires us to ask not simply whether the gut and brain communicate, but through which route, at which biological level, and with what evidence connecting one step to the next.

The axis begins with bidirectionality

The concept of a gut–brain axis predates modern microbiome science.

The gastrointestinal tract and central nervous system have long been known to communicate through autonomic nerves, the enteric nervous system, neuroendocrine pathways and immune signalling. What microbiome research added was another biologically active component within that network: the intestinal microbial ecosystem.¹–³

This changed the question from how does the gut communicate with the brain? to how might microbial activity participate in an already established gut–brain communication system?

That distinction is important.

The microbiota did not create the gut–brain axis.

It became part of our understanding of it.

Likewise, the brain is not simply a recipient of microbial signals. Psychological and physiological stress can alter autonomic output, intestinal transit, secretion, immune activity and epithelial physiology. These changes modify the habitat in which intestinal microorganisms live.⁴–⁶

The system is therefore reciprocal.

A microbial change can influence host physiology, while host physiology can reshape microbial ecology.

Direction cannot be assumed from association alone.

The enteric nervous system creates a local neural network

The gastrointestinal tract contains an extensive intrinsic nervous system.

The enteric nervous system coordinates motility, secretion, vascular function and other aspects of gastrointestinal physiology and communicates bidirectionally with the central nervous system through autonomic pathways.⁷,⁸

This places neural tissue in close functional proximity to the intestinal environment.

Microorganisms do not generally need to contact enteric neurons directly in order to influence neural signalling. Microbial metabolites, enteroendocrine mediators, epithelial signals and immune molecules can alter the activity of cells that communicate with enteric or extrinsic sensory neurons.²,³,⁸

The intestinal neural environment therefore acts as an intermediary.

A microbial signal can become a host neural signal before information ever reaches the brain.

This is an important conceptual boundary: microbial activity and neural activity are connected, but they are not the same biological event.

The vagus nerve provides a major neural route

The vagus nerve is one of the most intensively studied pathways in microbiota–gut–brain research.

Its sensory fibres convey information from visceral organs to the brainstem, while efferent activity contributes to regulation of gastrointestinal physiology and inflammatory responses.⁹–¹¹

Experimental studies have provided evidence that some microbiota-associated behavioural effects depend on intact vagal signalling. A landmark study by Bravo and colleagues found that ingestion of Lactobacillus rhamnosus JB-1 altered region-specific GABA receptor expression and stress-related behaviour in mice, while vagotomy prevented several of these effects.¹²

This provided compelling evidence that the vagus could participate in a microbe-associated gut–brain pathway under those experimental conditions.

But the interpretation should remain precise.

The study did not demonstrate that all probiotic effects are vagally mediated.

It did not show that bacteria travelled through the vagus.

And it did not establish that the same pathway produces equivalent behavioural effects in humans.

It demonstrated dependence on an intact neural route within a specific experimental model.

That is strong mechanistic evidence — at the level at which it was obtained.

Enteroendocrine cells connect luminal signals with neural pathways

The intestinal epithelium contains specialised enteroendocrine cells capable of sensing nutrients, microbial metabolites and other luminal signals.

These cells release hormones and signalling molecules including serotonin, peptide YY, glucagon-like peptide-1 and cholecystokinin, thereby linking intestinal conditions with neural, metabolic and endocrine responses.¹³–¹⁵

Some enteroendocrine cells form direct synaptic connections with sensory neurons, creating a rapid route through which information from the intestinal lumen can enter neural circuits.¹⁶,¹⁷

This has changed the conceptual picture of gut–brain signalling.

Communication does not always require a slowly circulating hormone to reach the brain.

Luminal information can be sensed by epithelial cells and translated into neural activity locally.

Microbial metabolites may participate in this process by interacting with receptors expressed by enteroendocrine cells.¹³–¹⁵

Again, the microorganism is not itself the neural signal.

The host translates microbial chemistry into host signalling.

Serotonin illustrates both connection and misconception

Serotonin is frequently invoked in discussions of the microbiota–gut–brain axis because a large proportion of the body’s serotonin is produced within the gastrointestinal tract.

Microbial signals can influence enterochromaffin-cell serotonin biosynthesis, and experimental work has shown that spore-forming gut bacteria can promote colonic serotonin production in mice.¹⁸

This is biologically important.

But it is often oversimplified.

Peripheral serotonin does not simply cross the blood–brain barrier and become brain serotonin. Gastrointestinal serotonin participates in intestinal motility, secretion, platelet biology and local signalling, while central serotonin is regulated within a distinct compartment.¹⁹

The relevance of microbial effects on intestinal serotonin therefore lies in the pathways through which peripheral serotonin biology influences gastrointestinal, neural, immune or metabolic signalling — not in a direct transfer of “gut serotonin” into the brain.

The distinction between shared molecule and shared compartment matters.

Immune signalling provides another communication network

The intestinal mucosa contains one of the body’s largest immune interfaces.

Microbial products and metabolites can influence epithelial and immune-cell activity, while immune mediators can enter the circulation or signal through neural pathways.²⁰–²²

Cytokines can affect neural function through several mechanisms. They can signal at circumventricular regions, influence endothelial and glial cells, activate peripheral afferent nerves and alter neuroendocrine activity.²¹,²²

This provides a plausible route through which intestinal immune activity can participate in brain signalling.

But the term inflammation is often used too loosely.

A change in one circulating cytokine is not equivalent to systemic inflammation.

Systemic inflammation is not equivalent to neuroinflammation.

And neuroinflammation is not a single measurable state.

Microbiota–immune–brain claims therefore require evidence at each level.

A microbial association with a circulating inflammatory marker does not, by itself, demonstrate that microbial activity caused inflammation in the brain.

Microglia provide a link between microbial signals and brain immunity

Microglia are the resident immune cells of the central nervous system and have become an important focus of microbiota–brain research.

Germ-free and microbiota-manipulation studies have demonstrated that the intestinal microbiota can influence microglial maturation and function. In mice, Erny and colleagues showed that absence of a complex microbiota produced altered microglial properties and that microbial metabolites, including short-chain fatty acids, contributed to restoration of microglial homeostasis.²³

Subsequent work has expanded understanding of how microbiota-derived or microbiota-modulated signals may influence microglial states across development, ageing and disease.²⁴

This is a powerful example of distal host–microbial communication.

It is also a reminder of the translational boundary.

Evidence that microbiota manipulation alters microglia in germ-free or experimentally manipulated mice does not establish that variation in the human faecal microbiome directly causes neuroinflammation.

The biological pathway is plausible and experimentally tractable.

Its relevance to a specific human phenotype must still be demonstrated.

The HPA axis connects stress physiology with the intestine

The hypothalamic–pituitary–adrenal axis provides another major route connecting brain and intestinal physiology.

Stress activates neuroendocrine pathways that influence cortisol or corticosterone release, autonomic activity, immune function and gastrointestinal physiology.⁴,²⁵

A seminal germ-free mouse study by Sudo and colleagues demonstrated an exaggerated HPA response to restraint stress in germ-free animals and showed that aspects of the response could be modified through microbial colonisation, particularly during early development.²⁶

This helped establish the microbiota as a potential contributor to development and regulation of stress physiology.

But the relationship is bidirectional.

Stress can alter intestinal motility, secretion, permeability and immune activity, all of which can modify microbial habitat.⁴–⁶,²⁵

Thus, an association between stress and microbiome composition does not tell us which came first.

The brain can shape the gut environment as readily as gut-derived signals can participate in stress regulation.

Microbial metabolites create chemical routes of communication

Microbial metabolism provides another major set of pathways through which intestinal ecology can influence host physiology.

Short-chain fatty acids, tryptophan-derived compounds, bile-acid metabolites and other microbial-associated molecules can interact with epithelial, immune, endocrine and neural systems.²⁷–³⁰

Some act primarily within the intestine.

Some enter systemic circulation.

Some influence host metabolic pathways that subsequently alter neural function.

Others may affect the integrity or signalling properties of peripheral and central barriers.³¹

This means that a metabolite does not need to enter the brain directly in order to influence brain physiology.

A microbial metabolite can alter immune-cell activity, endocrine signalling or vagal sensory input and thereby influence the nervous system indirectly.

The phrase microbial metabolite–brain signalling therefore describes several possible routes, not one mechanism.

Tryptophan metabolism illustrates pathway branching

Tryptophan sits at an especially important intersection between microbial, immune and neural biology.

It can enter the host kynurenine pathway, contribute to serotonin synthesis or be transformed by intestinal microorganisms into indole derivatives.²⁹,³²

These pathways have different biological consequences.

Inflammatory signalling can influence kynurenine metabolism.

Microbial indole derivatives can activate receptors including the aryl hydrocarbon receptor.

Peripheral tryptophan availability can influence substrate availability for central serotonin synthesis.²⁹,³²,³³

This makes statements such as “the microbiome affects serotonin through tryptophan” incomplete.

The relevant question is which tryptophan pathway has changed, in which compartment, and with what downstream consequence.

The metabolite is part of a network.

The intestinal barrier regulates exposure without eliminating communication

Intestinal-barrier function intersects with microbiota–gut–brain communication because the barrier regulates host exposure to luminal material.

But barrier permeability should not be understood simply as a gate that must remain completely closed.

Microbial metabolites and host–microbial signals cross or influence the intestinal interface during normal physiology. Barrier function determines the conditions under which molecules, antigens and microbial products encounter host tissues.³⁴,³⁵

Dysregulated permeability may increase exposure to luminal material and thereby alter immune or metabolic signalling.

That provides a biologically plausible route connecting intestinal-barrier dysfunction with systemic and potentially neural consequences.

But plausibility is not sufficient to establish a complete causal chain.

To demonstrate:

microbiota → altered barrier → systemic signal → brain effect

each transition requires evidence.

A zonulin-related biomarker alone cannot establish that sequence.

Neither can a microbiome association.

The blood–brain barrier adds another regulated interface

Signals reaching the circulation still encounter another biological boundary before directly entering brain tissue.

The blood–brain barrier regulates molecular exchange between blood and the central nervous system and responds dynamically to inflammatory, metabolic and neural signals.³¹,³⁶

Recent work has increasingly considered intestinal and brain barriers together rather than as isolated structures. Aburto and Cryan have argued for a broader view of gastrointestinal and brain barriers within microbiota–gut–brain communication, emphasising their dynamic regulation and potential interaction across physiological and disease contexts.³¹

This perspective is particularly useful.

The route from intestinal lumen to brain is not one barrier crossing.

It is a sequence of regulated interfaces.

The concept of living boundaries therefore applies at several levels of the microbiota–gut–brain system.

The brain changes the microbial environment indirectly

Much discussion focuses on signals travelling from microbiota to brain.

The reverse route is equally important.

Central and autonomic activity can alter gastrointestinal motility, secretion, blood flow, immune activity and epithelial function.⁴–⁶

Changes in transit alter the time available for microbial growth and metabolism.

Changes in secretion alter luminal chemistry.

Stress-related changes in feeding behaviour alter substrate availability.

Neuroendocrine and immune changes can alter epithelial and mucosal conditions.

The brain can therefore change microbial ecology without directly contacting microorganisms.

This is why the microbiota–gut–brain axis is genuinely bidirectional rather than a one-way microbial influence on the nervous system.

Multiple routes can operate simultaneously

Neural, immune, endocrine and metabolic pathways are often presented as separate categories for clarity.

Biologically, they interact.

A microbial metabolite can activate an enteroendocrine cell.

The enteroendocrine signal can activate a vagal afferent.

The same metabolite can influence immune cells.

Immune mediators can alter neural activity.

Stress hormones can alter epithelial physiology and microbial habitat.

A barrier change can modify exposure to microbial products and thereby alter immune signalling.

The routes are analytically separable but biologically entangled.

This is one reason why identifying a single mediator rarely explains the entire microbiota–gut–brain response.

The axis behaves more like a network than a pathway.

Timing matters

Microbiota–gut–brain communication also changes across the life course.

Early microbial colonisation coincides with development of the immune, endocrine and nervous systems. Experimental studies suggest that microbial absence or disruption during critical developmental windows can have effects that are not fully reproduced by manipulation later in life.²⁶,³⁷,³⁸

Ageing introduces another physiological context, with changes in microbial ecology, immunity, barrier function and neural biology occurring simultaneously.³⁹

The same microbial signal may therefore have different consequences at different stages of life.

Timing is part of mechanism.

From pathway to causal chain

The microbiota–gut–brain literature now contains substantial evidence that communication is biologically possible through multiple routes.

That is no longer the most difficult question.

The harder question is determining which route matters for a particular human outcome.

A convincing causal chain requires more than showing that:

  • a microorganism differs between groups;
  • a metabolite can affect neurons in vitro;
  • a cytokine is elevated;
  • or vagotomy changes behaviour in mice.

The pieces must connect.

Ideally, the microbial exposure is defined, the intermediate signal is measured, the relevant host pathway is manipulated, the downstream neural effect is demonstrated and the sequence is reproduced across complementary models.

Human evidence introduces additional requirements: temporality, control of confounding, measurement validity and clinical relevance.

The existence of many plausible routes makes this discipline more important, not less.

Communication without reductionism

The microbiota–gut–brain axis has become compelling because it connects systems that were historically studied separately.

Microbial ecology.

Barrier biology.

Immunology.

Endocrinology.

Neuroscience.

Metabolism.

Its scientific value lies in integrating these systems.

Its greatest interpretative risk is reducing that integration to a slogan.

The microbiota does not “talk to the brain” through one pathway.

The brain does not simply receive microbial messages.

Communication emerges through host systems that sense, transform and transmit information generated within the intestinal environment, while simultaneously reshaping that environment in return.

The microbiota–gut–brain axis is therefore best understood not as a line between gut and brain, but as a network of regulated biological routes connecting two complex ecosystems.

References

  1. Cryan JF, O’Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis. Physiological Reviews. 2019;99(4):1877–2013. doi:10.1152/physrev.00018.2018.
  2. Morais LH, Schreiber HL IV, Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders. Nature Reviews Microbiology. 2021;19(4):241–255. doi:10.1038/s41579-020-00460-0.
  3. Dinan TG, Cryan JF. The microbiome-gut-brain axis in health and disease. Gastroenterology Clinics of North America. 2017;46(1):77–89. doi:10.1016/j.gtc.2016.09.007.
  4. Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: regulation by the microbiome. Neurobiology of Stress. 2017;7:124–136. doi:10.1016/j.ynstr.2017.03.001.
  5. Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. Journal of Clinical Investigation. 2015;125(3):926–938. doi:10.1172/JCI76304.
  6. Madison A, Kiecolt-Glaser JK. Stress, depression, diet, and the gut microbiota: human-bacteria interactions at the core of psychoneuroimmunology and nutrition. Current Opinion in Behavioral Sciences. 2019;28:105–110. doi:10.1016/j.cobeha.2019.01.011.
  7. Furness JB. The enteric nervous system and neurogastroenterology. Nature Reviews Gastroenterology & Hepatology. 2012;9(5):286–294. doi:10.1038/nrgastro.2012.32.
  8. Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nature Reviews Gastroenterology & Hepatology. 2016;13(9):517–528. doi:10.1038/nrgastro.2016.107.
  9. Bonaz B, Bazin T, Pellissier S. The vagus nerve at the interface of the microbiota-gut-brain axis. Frontiers in Neuroscience. 2018;12:49. doi:10.3389/fnins.2018.00049.
  10. Breit S, Kupferberg A, Rogler G, Hasler G. Vagus nerve as modulator of the brain-gut axis in psychiatric and inflammatory disorders. Frontiers in Psychiatry. 2018;9:44. doi:10.3389/fpsyt.2018.00044.
  11. Browning KN, Verheijden S, Boeckxstaens GE. The vagus nerve in appetite regulation, mood, and intestinal inflammation. Gastroenterology. 2017;152(4):730–744. doi:10.1053/j.gastro.2016.10.046.
  12. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(38):16050–16055. doi:10.1073/pnas.1102999108.
  13. Gribble FM, Reimann F. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nature Reviews Endocrinology. 2019;15(4):226–237. doi:10.1038/s41574-019-0168-8.
  14. Martin AM, Sun EW, Rogers GB, Keating DJ. The influence of the gut microbiome on host metabolism through the regulation of gut hormone release. Frontiers in Physiology. 2019;10:428. doi:10.3389/fphys.2019.00428.
  15. Latorre R, Sternini C, De Giorgio R, Greenwood-Van Meerveld B. Enteroendocrine cells: a review of their role in brain-gut communication. Neurogastroenterology & Motility. 2016;28(5):620–630. doi:10.1111/nmo.12754.
  16. Kaelberer MM, Buchanan KL, Klein ME, et al. A gut-brain neural circuit for nutrient sensory transduction. Science. 2018;361(6408):eaat5236. doi:10.1126/science.aat5236.
  17. Bohórquez DV, Shahid RA, Erdmann A, et al. Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. Journal of Clinical Investigation. 2015;125(2):782–786. doi:10.1172/JCI78361.
  18. Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264–276. doi:10.1016/j.cell.2015.02.047.
  19. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132(1):397–414. doi:10.1053/j.gastro.2006.11.002.
  20. Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nature Neuroscience. 2017;20(2):145–155. doi:10.1038/nn.4476.
  21. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience. 2008;9(1):46–56. doi:10.1038/nrn2297.
  22. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nature Reviews Immunology. 2016;16(1):22–34. doi:10.1038/nri.2015.5.
  23. Erny D, Hrabě de Angelis AL, Jaitin D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience. 2015;18(7):965–977. doi:10.1038/nn.4030.
  24. Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK. Microbiome-microglia connections via the gut-brain axis. Journal of Experimental Medicine. 2019;216(1):41–59. doi:10.1084/jem.20180794.
  25. Farzi A, Fröhlich EE, Holzer P. Gut microbiota and the neuroendocrine system. Neurotherapeutics. 2018;15(1):5–22. doi:10.1007/s13311-017-0600-5.
  26. Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. Journal of Physiology. 2004;558(Pt 1):263–275. doi:10.1113/jphysiol.2004.063388.
  27. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345. doi:10.1016/j.cell.2016.05.041.
  28. Agus A, Clément K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70(6):1174–1182. doi:10.1136/gutjnl-2020-323071.
  29. Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host & Microbe. 2018;23(6):716–724. doi:10.1016/j.chom.2018.05.003.
  30. Wahlström A, Sayin SI, Marschall HU, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metabolism. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005.
  31. Aburto MR, Cryan JF. Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota-gut-brain axis. Nature Reviews Gastroenterology & Hepatology. 2024;21(7):416–429. doi:10.1038/s41575-024-00890-0.
  32. Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology. 2017;112(Pt B):399–412. doi:10.1016/j.neuropharm.2016.07.002.
  33. Gao K, Mu CL, Farzi A, Zhu WY. Tryptophan metabolism: a link between the gut microbiota and brain. Advances in Nutrition. 2020;11(3):709–723. doi:10.1093/advances/nmz127.
  34. Turner JR. Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology. 2009;9(11):799–809. doi:10.1038/nri2653.
  35. König J, Wells J, Cani PD, et al. Human intestinal barrier function in health and disease. Clinical and Translational Gastroenterology. 2016;7(10):e196. doi:10.1038/ctg.2016.54.
  36. Daneman R, Prat A. The blood-brain barrier. Cold Spring Harbor Perspectives in Biology. 2015;7(1):a020412. doi:10.1101/cshperspect.a020412.
  37. O’Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research. 2015;277:32–48. doi:10.1016/j.bbr.2014.07.027.
  38. Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends in Molecular Medicine. 2014;20(9):509–518. doi:10.1016/j.molmed.2014.05.002.
  39. O’Toole PW, Jeffery IB. Gut microbiota and aging. Science. 2015;350(6265):1214–1215. doi:10.1126/science.aac8469.

Authorship & AI Transparency — This work is entirely my own. AI-assisted tools are used solely for language review and clarity. I disclose their use in the interest of transparency and research integrity and take full responsibility for the final published work.

Perspective · Living Boundaries · Aug 24, 2026

The intestinal barrier is not a wall.

Living Boundaries concerns the health of communication: how a boundary receives, sets limits and adapts according to context. The intestinal barrier is the biological starting point for that larger question.